does tirzepatide have fewer side effects than semaglutide and are both injectable medications used in medical weight management—but they act on different metabolic pathways, which is why patient selection matters. Semaglutide (GLP-1 receptor agonist): • Primarily targets appetite Semaglutide vs tirzepatide side effects:

Monitor renal function in patients reporting adverse reactions to MOUNJARO that could lead to volume depletion, especially during dosage initiation and escalation of MOUNJARO

It's worth noting that the gastric emptying delay tends to diminish over time (tachyphylaxis), which may contribute to the improvement in GI symptoms many patients experience

07/28/25 Skytrofa (lonapegsomatropin-tcgd) Expanded indication July 28, 2025 - Ascendis Pharma announced the FDA approval of Skytrofa (lonapegsomatropin-tcgd), for the replacement of endogenous growth hormone in adults with growth hormone deficiency (GHD)

Im still feeling funny after I give myself the shot